AbbVie: all 2,243 studies

Page 18 of 23. Open to participants first (136), then studies with results posted, then the rest; newest registration first within each.

• Expanded Access to NavitoclaxNo longer availableNCT03592576
• Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic InjectionsCompletedNCT03559972Not applicable
• A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.Active, not recruitingNCT03539744Phase 3
• Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerActive, not recruitingNCT03539536Phase 2
• Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian FederationCompletedNCT03518047Phase 3
• A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)CompletedNCT03505892
• Expanded Access to Rovalpituzumab TesirineNo longer availableNCT03503890
• A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT03484520Phase 1
• A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03441555Phase 1
• Histological and Microbiological Evaluation of Late Occurring Nodules With Hyaluronic Acid Dermal FillersCompletedNCT03425721
• Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic LeukemiaCompletedNCT03415035
• Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104CompletedNCT03413319Phase 1
• A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian CancerWithdrawnNCT03400306Phase 1
• Physiopathologic Aspects and Quality of Life in Participants With Eye Dark CirclesCompletedNCT03400202
• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative ColitisActive, not recruitingNCT03398135Phase 3
• A Study to Assess Persistence, Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab (HUMIRA®)CompletedNCT03383263
• Impact of Severe Hepatic Impairment on Pharmacokinetics of Cenicriviroc and Its MetabolitesCompletedNCT03376841Phase 1
• A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient EnvironmentCompletedNCT03374917Phase 1
• A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) CancerTerminatedNCT03360006Phase 1
• A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433Active, not recruitingNCT03345823Phase 3
• Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6CompletedNCT03341871
• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenCompletedNCT03339128Phase 2
• Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis PatientsCompletedNCT03339102
• Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory DiseasesCompletedNCT03339089
• Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMDCompletedNCT03335852Phase 1
• Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung CancerWithdrawnNCT03334487Phase 3
• A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's DiseaseWithdrawnNCT03316898Phase 1
• A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)TerminatedNCT03316794Phase 1
• A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT03314181Phase 2
• A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid TumorsCompletedNCT03311477Phase 1
• A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in JapanCompletedNCT03311464Phase 3
• Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical PracticeCompletedNCT03310190
• CoolSculpting the FlanksStatus unknownNCT03304925Not applicable
• Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6CompletedNCT03303599
• A Study of SC-007 in Subjects With Advanced CancerTerminatedNCT03253185Phase 1
• A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in ChinaCompletedNCT03236870
• A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesCompletedNCT03236857Phase 1
• A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)CompletedNCT03234712Phase 1
• Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.Active, not recruitingNCT03229200Phase 4
• Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health ServiceCompletedNCT03223012
• A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT03219437Phase 3
• A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New DrugsCompletedNCT03201718
• Long Term Prospective Uncontrolled Study Of Earfold™ For The Treatment Of Prominent EarsCompletedNCT03194269Phase 4
• Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic MigraineWithdrawnNCT03193359Phase 3
• BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic MigraineWithdrawnNCT03193346Phase 3
• A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic LymphomaCompletedNCT03181126Phase 1
• Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical PracticeCompletedNCT03155243
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With PsoriasisTerminatedNCT03145948Phase 1
• A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)TerminatedNCT03145909Phase 1
• SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial CancersTerminatedNCT03138408Phase 1
• Expanded Access to Glecaprevir/ PibrentasvirApproved for marketingNCT03123965
• Expanded Access to ABT-414No longer availableNCT03123952
• Expanded Access to VeliparibNo longer availableNCT03123211
• A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's DiseaseActive, not recruitingNCT03105102Phase 3
• Real-World Outcome of Psoriasis Subjects in Korea on AdalimumabCompletedNCT03099083
• A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung CancerCompletedNCT03086239Phase 1
• A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic MalignanciesCompletedNCT03082209Phase 1
• A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid TumorsCompletedNCT03071757Phase 1
• Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)CompletedNCT03043287
• A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal CancerTerminatedNCT03035279Phase 1
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's DiseaseCompletedNCT03033498Phase 1
• A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life ConditionsTerminatedNCT03017014
• A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)Active, not recruitingNCT03006068Phase 3
• Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)CompletedNCT03003416
• Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa SubjectsCompletedNCT03001115
• A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid TumorsCompletedNCT03000257Phase 1
• A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsActive, not recruitingNCT02988960Phase 1
• A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian FederationCompletedNCT02988674
• A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)CompletedNCT02966782Phase 1
• A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaActive, not recruitingNCT02966756Phase 2
• A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid TumorsCompletedNCT02955251Phase 1
• Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the EyeTerminatedNCT02951975
• A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer TreatmentWithdrawnNCT02951117Phase 1
• Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2CompletedNCT02945228
• Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02944396Phase 1
• A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)CompletedNCT02942290Phase 1
• HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitisCompletedNCT02916017
• Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's DiseaseCompletedNCT02906488
• Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)Active, not recruitingNCT02899052Phase 2
• Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA )CompletedNCT02896985
• Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of IllnessCompletedNCT02896920
• Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous DepressionsCompletedNCT02877069Phase 4
• A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung CancerCompletedNCT02874664Phase 1
• Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)CompletedNCT02863705Phase 4
• CPC-201 Alzheimer's Disease Type Dementia: PET StudyWithdrawnNCT02860065Phase 2
• Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMDCompletedNCT02859766Phase 1
• Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic AlopeciaCompletedNCT02848300Phase 1
• A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung CancerTerminatedNCT02819999Phase 1
• Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)WithdrawnNCT02806362Phase 3
• Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst StageCompletedNCT02788617
• Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life SettingCompletedNCT02786576
• Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to MethotrexateWithdrawnNCT02786563
• This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic ArthritisCompletedNCT02772601Phase 1
• Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life ConditionsCompletedNCT02738125
• Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX StudyCompletedNCT02731911
• A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in GreeceCompletedNCT02713295
• Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial InfectionTerminatedNCT02688790Phase 1
• A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) PatientsCompletedNCT02687828
• Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and DigoxinCompletedNCT02685462Phase 1
• Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in CombinationCompletedNCT02684799Phase 1

← AbbVie overview and focus areas